Author:
Jiang Yinghua,Liu Ning,Han Jinrui,Li Yadan,Spencer Pierce,Vodovoz Samuel J.,Ning Ming-Ming,Bix Gregory,Katakam Prasad V. G.,Dumont Aaron S.,Wang Xiaoying
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Clinical Neurology,General Neuroscience
Reference139 articles.
1. Whiteley WN, Thompson D, Murray G, Cohen G, Lindley RI, Wardlaw J, et al. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial. Stroke. 2014;45(4):1000–6.
2. Chapman SN, Mehndiratta P, Johansen MC, McMurry T, Johnston KC, Southerland AM. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag. 2014;10:75–87.
3. Carbone F, Busto G, Padroni M, Bernardoni A, Colagrande S, Dallegri F, et al. Radiologic cerebral reperfusion at 24 h predicts good clinical outcome. Transl Stroke Res. 2019;10(2):178–88.
4. Weintraub MI. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke. 2006;37(7):1917–22.
5. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59(6):862–7.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献